Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis

Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis

The pathogenesis of non-alcoholic steatohepatitis (NASH) involves the simultaneous interaction of multiple factors such as lipid accumulation, oxidative stress, and inflammatory response. Here, the effect of human serum albumin (HSA) fused to thioredoxin (Trx) on NASH was investigated. Trx is known...

Full description

Bibliographic Details
Main Authors:	Ryota Murata, Hiroshi Watanabe, Ryotaro Iwakiri, Mayuko Chikamatsu, Takao Satoh, Isamu Noguchi, Kengo Yasuda, Ayano Nishinoiri, Takuma Yoshitake, Hiroto Nosaki, Hitoshi Maeda, Toru Maruyama
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Heliyon
Subjects:	Albumin fusion Thioredoxin Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Oxidative stress Inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024015160

Similar Items

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis
by: Kanehiko Suwa, et al.
Published: (2020-01-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
by: Ana Šinkovec, et al.
Published: (2021-10-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
by: Daryl Ramai, et al.
Published: (2021-02-01)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
by: Yu Junjie, et al.
Published: (2023-01-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
by: Alessandro Federico, et al.
Published: (2021-04-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
by: Sina Ghandian, et al.
Published: (2022-03-01)

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
by: Qingfu Zhu, et al.
Published: (2022-07-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2020-10-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
by: Yeong Yeh Lee, et al.
Published: (2023-01-01)

Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis
by: Yuki Tada, et al.
Published: (2022-10-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
by: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Published: (2022-07-01)

Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study
by: Ji Xiong, et al.
Published: (2015-08-01)

Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway
by: Kyung Eun Kim, et al.
Published: (2023-10-01)

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis
by: Dong Hun Lee, et al.
Published: (2022-12-01)

Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats
by: Guoying Zhu, et al.
Published: (2022-07-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
by: Stefania De Lorenzo, et al.
Published: (2020-10-01)

The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
by: Osama Hamid, et al.
Published: (2022-09-01)

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis
by: Atsuko Takai, et al.
Published: (2020-02-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
by: Weiwei He, et al.
Published: (2023-01-01)

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
by: Masatoshi Kudo
Published: (2021-07-01)

A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population
by: Qingling Wang, et al.
Published: (2022-06-01)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
by: Zhen Yang, et al.
Published: (2023-03-01)

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action
by: Vanessa D. de Mello, et al.
Published: (2017-04-01)

Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis
by: Helena Castañé, et al.
Published: (2023-11-01)

A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model
by: Natalia Muñoz-Durango, et al.
Published: (2020-12-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
by: János Fehér, et al.
Published: (2005-04-01)

Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: A systematic review
by: Arun J. Sanyal, et al.
Published: (2024-05-01)

Plasma Lipids Profile in the Prediction of Non-Alcoholic Steatohepatitis in Adults: A Case-Control Study
by: Georgios Kalopitas, et al.
Published: (2023-08-01)